Alimta 500mg Pemetrexed Injection

Trade Name: Alimta

Manufacturer: Eli Lilly

Presentation: Injection

Strength: 500mg

What is the function of Alimta 500mg?

Alimta 500mg and platinum are chemotherapies that are used to treat advanced nonsquamous non-small cell lung cancer ( Your body’s own immune system is used to locate and fight cancer cells when you add KEYTRUDA to this combo.

Alimta is provided in a distinctive manner?

The recommended dose of ALIMTA on Day 1 of each 21-day cycle is 500 mg/m2 administered as an intravenous infusion over 10 minutes. The recommended cisplatin dose is 75 mg/m2 over two hours, beginning 30 minutes after ALIMTA delivery.

What are Alimta’s side effects?

  • Nausea
  • vomiting
  • loss of appetite
  • diarrhoea
  • stomach discomfort
  • taste changes
  • constipation
  • mouth sores
  • and weariness is all possible side effects. Nausea, vomiting, and diarrhoea are all common side effects. Your doctor may recommend medication to prevent or alleviate nausea, vomiting, or diarrhoea in some circumstances. For more click here.

Alimta is a type of medication?

Alimta 500mg is a brand name for Pemetrexed, a generic medication. When referring to the generic medicine name Pemetrexed, health care practitioners may use the trade name Alimta. Type of medication: Pemetrexed is an anti-cancer chemotherapeutic medication (sometimes known as “antineoplastic” or “cytotoxic”).

Is Alimta known to induce mouth sores?

7 to 10 days after taking this medication, you may have mouth sores and/or a sore throat. Brushing your teeth with a soft-bristle toothbrush is recommended. You may have a burning sensation in your mouth or on your lips, as well as redness. It is critical to maintain what is the best way to dilute Alimta?
A suitable amount of the reconstituted ALIMTA solution must be diluted further in a 0.9 per cent Sodium Chloride Injection (preservative-free) solution, resulting in a total volume of 100 ml. ALIMTA is administered as a 10-minute intravenous infusion. a healthy mouth.

Is Alimta capable of causing pneumonitis?

Methotrexate-induced pulmonary toxicity affects 2–8% of patients and can vary from pneumonitis to neoplasms. Methotrexate-induced pneumonitis might take the form of pemetrexed pneumonitis, BOOP, or even fibrosis.

If you are looking for another product or brand click here.